‘Time for Five’ coalition launches global petition targeting medical test maker Cepheid and parent corporation Danaher

Ahead of World Tuberculosis (TB) Day, Doctors Without Borders/Médecins Sans Frontières (MSF) protested alongside other global health activists outside the headquarters of US corporation Danaher, which owns diagnostics maker Cepheid, demanding they drop the price to US$5 for all their ‘GeneXpert’ medical tests that they sell in low- and middle-income countries, for diseases such as […]

Read More… from ‘Time for Five’ coalition launches global petition targeting medical test maker Cepheid and parent corporation Danaher

MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA

A clinician picking ARVs for a patient at Maram Dispensary in Ndhiwa sub county, Homa Bay County.

Signing confidentiality clauses on supply & pricing blocks transparency and accountability  Today, Doctors Without Borders/Médecins Sans Frontières(MSF) asked ViiV Healthcare to withdraw conditions in negotiations for a purchase agreement that are holding up procurement of the preventative HIV drug cabotegravir long-acting (CAB-LA) for key and vulnerable populations*, due to the pharmaceutical corporation’s last-minute insertion of terms […]

Read More… from MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA

Pharmaceutical corporation ViiV must improve its failing access strategy for HIV prevention drug

  Doctors Without Borders/Médecins Sans Frontières (MSF) calls on the pharmaceutical corporation ViiV to immediately provide transparency on the current available volume and planned geographic distribution of the HIV prevention medicine long-acting cabotegravir (CAB-LA) in order to urgently expedite the drug’s access for people in high-HIV-burden low- and middle-income countries (LMICs), where it could have the biggest […]

Read More… from Pharmaceutical corporation ViiV must improve its failing access strategy for HIV prevention drug

Access to Medicines

Doctors Without Borders/Médecins Sans Frontières (MSF) continually calls on governments, pharmaceutical companies, researchers, and others to place lives before profits and commit to making essential medicines available and accessible to the patients around the world who need them most. As a humanitarian medical organization driven by the belief that everyone should have access to essential […]

Read More… from Access to Medicines

Lives over profits petition: Foreign Committee takes on MSF’s recommendations towards more equitable access to medicines

In October 2020, we delivered a petition with more than 91,000 signatures to Canada’s Minister of Health, calling on the Canadian government to take immediate steps to ensure fair, affordable and equitable access to any medicines, vaccines or other health technologies developed with Canadian public funds, including in response to the COVID-19 pandemic. WATCH THE RECAP The […]

Read More… from Lives over profits petition: Foreign Committee takes on MSF’s recommendations towards more equitable access to medicines

MSF tells MPs that Canada must do more to address inequitable global access to vaccines

The following is a transcript of opening words by Jason Nickerson, Doctors Without Borders/Médecins Sans Frontières (MSF) Humanitarian Representative to Canada to the Canadian Parliamentary Standing Committee on International Trade in May 2021.  Hello, thank you for having us. We’re going to speak to two issues that are part of the Committee’s study, from the perspective of our […]

Read More… from MSF tells MPs that Canada must do more to address inequitable global access to vaccines

Skip to content